Ergoteles’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ergoteles’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33,102	Closed	-$7.18M	–	1781
2021 Q1	$7.18M	Buy	+33,102	New	+$6.22M	0.22%	122

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Ergoteles's GWPH Position: Q2 2021 in Review

Ergoteles sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 33,102 shares — an estimated $7.18M sold.

Ergoteles first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $7.18M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Ergoteles reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Ergoteles sold 33,102 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $7.18M.
Ergoteles first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Ergoteles's GW Pharmaceuticals Plc American Depositary Shares position peaked at $7.18M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.